Evidence map›Paper›PMID 36437853›Full record

ArticleBMJ neurology open2022

Imaging of extrapontine myelinolysis preceding central pontine myelinolysis in a case of ornithine transcarbamylase deficiency with hyperammonaemia and hypokalaemia.

Yuya Tanaka, Mitsuru Matsuki, Rieko Furukawa, Waka Nakata, Yoshio Sakurai, Sayaka Ajihara, Akiko Kawano, Harushi Mori

Open access · diamondAbstract read
In one paragraph

Article in BMJ neurology open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yuya TanakaDepartment of Radiology, Jichi Medical University, Shimotsuke, Tochigi, Japan.ORCID 0000-0003-0260-0424
Mitsuru MatsukiDepartment of Pediatric Medical Imaging, Jichi Children's Medical Center Tochigi, Shimotsuke, Tochigi, Japan.
Rieko FurukawaDepartment of Pediatric Medical Imaging, Jichi Children's Medical Center Tochigi, Shimotsuke, Tochigi, Japan.
Waka NakataDepartment of Pediatric Medical Imaging, Jichi Children's Medical Center Tochigi, Shimotsuke, Tochigi, Japan.
Yoshio SakuraiDepartment of Pediatrics, Saitama Medical Center, Kawagoe, Saitama, Japan.
Sayaka AjiharaDepartment of Pediatrics & Clinical Genomics, Saitama Medical University, Iruma, Saitama, Japan.
Akiko KawanoDepartment of Pediatrics, Saitama Medical Center, Kawagoe, Saitama, Japan.
Harushi MoriDepartment of Radiology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Jichi Medical University · JPSocial Insurance Saitama Chuo Hospital · JPSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with ornithine transcarbamylase deficiency (OTCD) often present with severe hyperammonaemia. We report a case of osmotic demyelination syndrome (ODS) secondary to the treatment of hyperammonaemia due to OTCD, a disease requiring early diagnosis, as it can have a severe prognosis. Case: A girl toddler was brought to the hospital with a complaint of somnolence, presenting with hyperammonaemia and liver failure, and was diagnosed with OTCD. Treatment was started immediately, and the ammonia level returned to the normal range within 24 hours. On days 13-20, another treatment was commenced for re-elevated ammonia levels, which subsequently returned to within the reference range; however, mildly impaired consciousness persisted. Hypokalaemia coincided with temporary intravenous treatment and continuous haemodialysis. T2-weighted magnetic resonance images revealed lesions as high-signal areas in the bilateral putamen on day 11 (extrapontine myelinolysis (EPM)) and in the pons on day 51 (central pontine myelinolysis (CPM)). Consequently, ODS was diagnosed. Conclusion: When interpreting magnetic resonance images of patients under acute treatment for hyperammonaemia due to OTCD, a condition that may be complicated by hypokalaemia, paying attention to findings suggesting EPM may help detect ODS before CPM appears and may improve patient prognosis.

Indexed as

METABOLIC DISEASEMRIMYELOPATHYNEURORADIOLOGYPAEDIATRIC

Identifiers

PMID36437853
PMCPMC9685229
OpenAlexW4309679156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.